Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute

Sun Pharma to buy 16.33 percent stake in Surgimatix for over Rs 25 crore

Ruchika Sharma21 Feb 2024 3:21 PM IST

New Delhi: Pharma major, Sun Pharmaceutical Industries Ltd, on Tuesday said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm...

Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Sanofi consumer healthcare spin-off attracts private equity interest: Sources

Ruchika Sharma21 Feb 2024 2:30 PM IST

London: Drugmaker Sanofi's consumer healthcare division has attracted interest from private equity funds as the French group prepares to spin out...

Viatris Aurangabad facility gets Global Minimized Risk of Antimicrobial Resistance Certification

Ruchika Sharma21 Feb 2024 1:30 PM IST

India: Viatris Inc., a global healthcare company, has announced that its Aurangabad, India, facility has received certification from the...

Delhi: Medicines worth Rs 52 lakh seized at IGI Airport, 3 arrested

Ruchika Sharma21 Feb 2024 12:30 PM IST

New Delhi: The Central Industrial Security Force (CISF) has detected huge quantities of different medicines valued around Rs 52 lakh from three...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

JnJ gets USFDA nod for Bi-weekly dose of blood cancer therapy Tecvayli

Ruchika Sharma21 Feb 2024 11:39 AM IST

United States: The U.S. Food and Drug Administration has approved a bi-weekly dose of Johnson & Johnson's blood cancer therapy Tecvayli, the...

Eisai, nippon medac receive approval for Metoject subcutaneous injection pen (methotrexate) pen-type autoinjector in Japan

Ruchika Sharma20 Feb 2024 4:00 PM IST

The drug can be self-injected in two steps (1- removing the cap, 2- pressing the pen against the skin).

German drugmaker Bayer cuts dividends to legal minimum to reduce debt

Ruchika Sharma20 Feb 2024 2:50 PM IST

Frankfurt: German drugmaker Bayer said that it was amending its dividend policy to pay the legal minimum for a period of three years to reduce...

Eli Lilly reports strong response for Mounjaro in India

EU drug regulator to review use of Eli Lilly Mounjaro in multi-dose pen

Ruchika Sharma20 Feb 2024 1:30 PM IST

Frankfurt: The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and...

AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate

AstraZeneca concludes acquisition of Icosavax

Ruchika Sharma20 Feb 2024 12:30 PM IST

Cambridge: AstraZeneca has announced the successful completion of the acquisition of Icosavax, Inc., a US-based clinical-stage biopharmaceutical...

Pfizer gets EU nod for ulcerative colitis drug Velsipity

Ruchika Sharma20 Feb 2024 11:30 AM IST

The approval, applicable in all 27 countries of the European Union, is based on studies from two late-stage trials that showed the drug was effective...

CDSCO releases regulatory guidelines for sampling of drugs, cosmetics and medical devices

Ruchika Sharma19 Feb 2024 6:30 PM IST

New Delhi: In order to streamline and rationalize the sampling procedure of drugs, cosmetics and medical devices and maintaining a centralized monthly...

AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report

AstraZeneca-Daiichi Sankyo application for Datopotamab deruxtecan accepted in US for patients with previously treated advanced nonsquamous non-small cell lung cancer

Ruchika Sharma19 Feb 2024 4:30 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok